Your browser doesn't support javascript.
loading
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
Cremer, Sebastian; Pilgram, Lisa; Berkowitsch, Alexander; Stecher, Melanie; Rieg, Siegbert; Shumliakivska, Mariana; Bojkova, Denisa; Wagner, Julian Uwe Gabriel; Aslan, Galip Servet; Spinner, Christoph; Luxán, Guillermo; Hanses, Frank; Dolff, Sebastian; Piepel, Christiane; Ruppert, Clemens; Guenther, Andreas; Rüthrich, Maria Madeleine; Vehreschild, Jörg Janne; Wille, Kai; Haselberger, Martina; Heuzeroth, Hanno; Hansen, Arne; Eschenhagen, Thomas; Cinatl, Jindrich; Ciesek, Sandra; Dimmeler, Stefanie; Borgmann, Stefan; Zeiher, Andreas.
Afiliación
  • Cremer S; Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.
  • Pilgram L; German Center for Cardiovascular Research DZHK, Partner Site Rhine-Main, Berlin, Germany.
  • Berkowitsch A; Cardiopulmonary Institute, Goethe University Frankfurt, Frankfurt, Germany.
  • Stecher M; Department of Internal Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Rieg S; Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.
  • Shumliakivska M; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Bojkova D; Internal Medicine II, Department of Infectious Diseases, Freiburg University Hospital, Freiburg, Germany.
  • Wagner JUG; Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt, Germany.
  • Aslan GS; Institute of Medical Virology, University of Frankfurt, Frankfurt, Germany.
  • Spinner C; Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt, Germany.
  • Luxán G; Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt, Germany.
  • Hanses F; Department of Internal Medicine II, Technical University of Munich, Hospital rechts der Isar, Munich, Germany.
  • Dolff S; German Center for Cardiovascular Research DZHK, Partner Site Rhine-Main, Berlin, Germany.
  • Piepel C; Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Frankfurt, Germany.
  • Ruppert C; University Hospital Regensburg, Regensburg, Germany.
  • Guenther A; Department of Infectious Diseases, University Hospital Essen, Essen, Germany.
  • Rüthrich MM; Department of Internal Medicine I, Hospital Bremen-Mitte, Bremen, Germany.
  • Vehreschild JJ; Department of Internal Medicine II, Giessen University, Giessen, Germany.
  • Wille K; Department of Internal Medicine II, Giessen University, Giessen, Germany.
  • Haselberger M; Department of Internal Medicine II, Jena University, Jena, Germany.
  • Heuzeroth H; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Hansen A; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, University of Bochum, Minden, Germany.
  • Eschenhagen T; Department of Internal Medicine I, Hospital Passau, Passau, Germany.
  • Cinatl J; Department of Emergency and Intensive Care Medicine, Klinikum Ernst von Bergmann, Potsdam, Germany.
  • Ciesek S; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dimmeler S; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Borgmann S; Institute of Medical Virology, University of Frankfurt, Frankfurt, Germany.
  • Zeiher A; Institute of Medical Virology, University of Frankfurt, Frankfurt, Germany.
PLoS One ; 16(10): e0258684, 2021.
Article en En | MEDLINE | ID: mdl-34673795
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema de Registros / Antagonistas de Receptores de Angiotensina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 / Hipertensión Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema de Registros / Antagonistas de Receptores de Angiotensina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 / Hipertensión Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Alemania